Company Valuation: GSK plc

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 80,458 58,381 59,112 54,944 73,201 73,865 - -
Change - -27.44% 1.25% -7.05% 33.23% 0.91% - -
Enterprise Value (EV) 1 100,296 75,578 74,152 68,039 87,654 95,756 93,042 90,376
Change - -24.65% -1.89% -8.24% 28.83% 9.24% -2.83% -2.87%
P/E 18.6x 3.93x 11.9x 21.3x 12.9x 14.9x 11.9x 11x
PBR 5.34x 5.47x 4.4x 4.02x 4.51x 4.24x 4.11x 3.54x
PEG - 0x -0.2x -0.4x 0x -1.2x 0.5x 1.3x
Capitalization / Revenue 2.36x 1.99x 1.95x 1.75x 2.24x 2.18x 2.09x 2.03x
EV / Revenue 2.94x 2.58x 2.45x 2.17x 2.68x 2.83x 2.64x 2.48x
EV / EBITDA 8.85x 7.23x 6.37x 6.36x 7.77x 8.31x 7.6x 7.18x
EV / EBIT 11.4x 9.27x 8.44x 7.44x 8.96x 9.25x 8.48x 7.88x
EV / FCF 22.6x 12.1x 13.6x 13x 13.7x 20x 19.7x 15.4x
FCF Yield 4.42% 8.28% 7.36% 7.67% 7.32% 4.99% 5.07% 6.49%
Dividend per Share 2 1 0.6125 0.58 0.61 0.66 0.6958 0.7479 0.7822
Rate of return 4.98% 4.26% 4% 4.53% 3.62% 3.78% 4.06% 4.25%
EPS 2 1.082 3.662 1.216 0.632 1.411 1.233 1.543 1.674
Distribution rate 92.4% 16.7% 47.7% 96.5% 46.8% 56.4% 48.5% 46.7%
Net sales 1 34,114 29,324 30,328 31,376 32,667 33,833 35,276 36,462
EBITDA 1 11,330 10,449 11,635 10,693 11,278 11,526 12,248 12,592
EBIT 1 8,806 8,151 8,786 9,148 9,783 10,348 10,973 11,465
Net income 1 4,385 14,956 4,928 2,575 5,716 4,918 6,109 6,668
Net Debt 1 19,838 17,197 15,040 13,095 14,453 21,891 19,177 16,511
Reference price 2 20.08 14.38 14.50 13.46 18.24 18.42 18.42 18.42
Nbr of stocks (in thousands) 4,006,383 4,060,999 4,076,145 4,080,519 4,012,126 4,008,939 - -
Announcement Date 2/9/22 2/1/23 1/31/24 2/5/25 2/4/26 - - -
1GBP in Million2GBP
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
14.94x2.83x8.31x3.78% 96.76B
39.41x13.36x28.32x0.51% 1,200B
36.94x6.65x18.71x1.97% 651B
36.49x8.39x17.36x2.41% 506B
21.41x5.17x12.95x2.53% 377B
94.91x5.47x23.3x2.54% 330B
22.98x5.56x13.52x2.87% 288B
23.04x4.63x13.15x1.9% 272B
22.49x6.97x12.81x2.32% 236B
-39.14x7.25x45.66x1.98% 206B
Average 27.35x 6.63x 19.41x 2.28% 416B
Weighted average by Cap. 33.80x 8.32x 21.20x 1.82%

Y-o-Y evolution of P/E

Valuation ratios - P/E - GSK plc

Historical PBR trend

Valuation ratios - PBR - GSK plc

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - GSK plc

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - GSK plc


Year-on-year evolution of the Yield

Valuation ratios - Yield - GSK plc